Lee's Pharmaceutical Holdings Limited
LPCUF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $347 | $347 | $371 | – |
| % Growth | 0% | -6.3% | – | – |
| Cost of Goods Sold | $167 | $167 | $169 | – |
| Gross Profit | $180 | $180 | $201 | – |
| % Margin | 51.8% | 51.8% | 54.3% | – |
| R&D Expenses | $21 | $21 | $49 | – |
| G&A Expenses | $51 | $51 | $49 | – |
| SG&A Expenses | $127 | $127 | $163 | – |
| Sales & Mktg Exp. | $76 | $76 | $108 | – |
| Other Operating Expenses | -$2 | -$2 | -$34 | – |
| Operating Expenses | $146 | $146 | $179 | – |
| Operating Income | $34 | $34 | $23 | – |
| % Margin | 9.7% | 9.7% | 6.1% | – |
| Other Income/Exp. Net | -$3 | -$3 | -$4 | – |
| Pre-Tax Income | $30 | $30 | $19 | – |
| Tax Expense | $5 | $5 | $12 | – |
| Net Income | $34 | $34 | $15 | – |
| % Margin | 9.7% | 9.7% | 4.1% | – |
| EPS | 0.057 | 0.057 | 0.026 | – |
| % Growth | 0% | 119.2% | – | – |
| EPS Diluted | 0.057 | 0.057 | 0.026 | – |
| Weighted Avg Shares Out | 589 | 589 | 589 | – |
| Weighted Avg Shares Out Dil | 589 | 589 | 589 | – |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | – |
| Interest Expense | $0 | $0 | $0 | – |
| Depreciation & Amortization | $36 | $36 | $8 | – |
| EBITDA | $69 | $69 | $41 | – |
| % Margin | 19.9% | 19.9% | 11.2% | – |